House committee advances key PBM bills in step with Senate counterparts

The House En­er­gy & Com­merce Com­mit­tee on Wednes­day ad­vanced sev­er­al pieces of leg­is­la­tion seek­ing to re­quire more trans­paren­cy from phar­ma­cy ben­e­fit man­agers, mov­ing them one step clos­er to be­com­ing law.

Dur­ing an ex­pan­sive full com­mit­tee markup of more than 40 bills, the law­mak­ers con­sid­ered a slate of health­care pro­pos­als, in­clud­ing leg­is­la­tion that would al­low for Medicare flex­i­bil­i­ties for cov­er­ing biosim­i­lars and putting up guardrails around PBM com­pen­sa­tion prac­tices.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.